Clinical trial

Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma

NCT00971061

Study summary

ClinicalTrials.gov

Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Ahmed valve implant Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Molteno single-plate implant (MSPI) Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-01-01

PhasePHASE3

Conditions

Refractory Glaucomaunresolved

Interventions

Ahmed valve implantDEVICE

Molteno single-plate implant (MSPI)DEVICE

Sponsors & collaborators

Vanak Eye Surgery Centerlead sponsor

Mapped research locations

TehranTehran Province, Iran1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00971061 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.